Tracking Outcomes of Deep Brain Stimulation for Parkinson Disease, Essential Tremor, and Dystonia

What this Trial Is About

Researchers are collecting long-term clinical outcomes of patients who receive deep brain stimulation DBS to treat movement disorders such as Parkinson disease, essential tremor, and dystonia. The study is observational and aims to retrospectively compare and track the risks, benefits, and complications associated with this therapy over time. This research is led by Washington University School of Medicine. Participants undergo deep brain stimulation, which involves high-frequency electrical stimulation of deep brain nuclei to manage movement disorders. There are no experimental drug treatments involved, and the study follows patients who have already received DBS to observe their progress and clinical outcomes. During the study, researchers monitor changes in patient movement and function using tools like the Unified Parkinsons Disease Rating Scale UPDRS, measuring changes at one year after DBS compared to before surgery. The study tracks these outcomes over time to better understand the effects and safety of DBS in this patient population. Participation involves clinical assessments and follow-up evaluations.

Clinical Outcomes for Deep Brain Stimulation